摘要 |
The present invention provides compounds of formula (I) including stereoisomers, prodrugs and pharmaceutically acceptable salts or solvates thereof (Formula (I)) wherein the dashed line may represent a double bond; R is aryl or heteroaryl, each of which may be substituted by 1 to 4 groups J selected from: halogen, C1-C6 alkyl, C1-C6 alkoxy, halo C1-C6 alkyl, C2-C6 lkenyl, C2-C6 alkynyl, halo C1-C6 alkoxy, -C(O)R2, nitro, hydroxy, -NR3R4, cyano and or a group Z; R1 is hydrogen, C3-C7 cycloalkyl, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 thioalkyl, C2-C6 alkenyl, C2-C6 alkynyl, halo C1-C6 alkyl, hal o Cl~-C6 alkoxy, halogen, NR3R4 or cyano; D, G is.-C- optionally substituted; X is carbon or nitrogen; Y is nitrogen or -C- optionally substituted; W is a 4 -8 membered ring, which may be saturated or may contain one to three double bonds, and in which: - one carbon atom is replaced by a carbonyl or S(O)m; a nd - one to four carbon atoms may optionally be replaced by oxygen, nitrogen or NR12, S(O)m, carbonyl, and such ring may be further substituted by 1 to 8 substituents; Z is a 5-6 membered heterocycle, which may be substituted by 1 to 8 R5 groups or a phenyl ring, which may be substituted by 1 to 4 substituents; m is an integer from 0 to 2. to processes for their preparatio n, to pharmaceutical compositions containing them and to their use in the treatment of conditions mediated by corticotropin-releasing factor (CRF).</S DOAB>
|
申请人 |
NEUROCRINE BIOSCIENCES, INC.;SB PHARMCO PUERTO RICO INC. |
发明人 |
DI FABIO, ROMANO;FERIANI, ALDO;FAZZOLARI, ELETTRA;CONTINI, STEFANIA;CASTIGLIONI, EMILIANO;MATTIOLI, MARIO;ANDREOTTI, DANIELE;GENTILE, GABRIELLA;BERNASCONI, GIOVANNI;ST-DENIS, YVES;SABBATINI, FABIO;MINGARDI, ANNA |